Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 3, 2019
Aileron Therapeutics Completes $26M Private Placement
WATERTOWN, Mass., April 03, 2019 (GLOBE NEWSWIRE) --  Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and ...
April 3, 2019
Genocea to Present at 18th Annual Needham Healthcare Conference
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president ...
April 3, 2019
InspireMD, Inc. Announces Proposed Public Offering of Common Stock
TEL AVIV, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke ...
April 3, 2019
OSE Immunotherapeutics Presents New Clinical and Preclinical Data on its Immuno-Oncology Portfolio at AACR 2019
NANTES, France, April 02, 2019 (GLOBE NEWSWIRE) -- OSEImmunotherapeutics (ISIN: FR0012127173; Mnémo: OSE), today announced that new clinical and preclinical data on its products in ...
April 3, 2019
Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS™ Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (GNCA), a biopharmaceutical company developing neoantigen cancer immunotherapies, today announced the presentation of data ...
April 3, 2019
Vermillion Exhibits OVA1 Ethnic Disparity Performance Poster at the American Association for Cancer Research (AACR) Annual Meeting
AUSTIN, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is being represented at the ...
April 3, 2019
ADMA Receives Department of Health and Human Services U.S. License
RAMSEY, N.J. and BOCA RATON, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
April 3, 2019
Santhera Provides Update on Near-term Corporate Financing Initiatives
Pratteln, Switzerland, April 3, 2019 - Santhera Pharmaceuticals (SANN.SW) announces that it has entered into a CHF 15.0 million credit line facility and is providing an update ...
April 3, 2019
Oncolytics Biotech(R) to Present at the 18th Annual Needham Healthcare Conference
CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / April 3, 2019 / Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic ...
April 3, 2019
Soleno Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
REDWOOD CITY, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
April 3, 2019
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), announced the closing of ...
April 3, 2019
Gina DiGuglielmo Joins Relmada as Vice President and Head of Clinical Operations
NEW YORK, April 3, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, ...
April 3, 2019
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR
NEW YORK, April 3, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) highlighted data from its poster presentation at the AACR or American Association ...
April 3, 2019
Sierra Reports Late-Breaking SRA141 Preclinical Data in Poster at AACR 2019
VANCOUVER , April 3, 2019 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment ...
April 3, 2019
Catalyst Biosciences to Present at The Needham & Company 18th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer, will present ...
April 3, 2019
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT002, Nasal Naltrexone, for Treatment of Alcohol Use Disorder
SANTA MONICA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today ...
April 3, 2019
Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10
SAN DIEGO, April 3, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will ...
April 3, 2019
Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
April 3, 2019
Y-mAbs Therapeutics To Present At The H.C. Wainwright Global Life Sciences Conference in London
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (YMAB) a late-stage clinical biopharmaceutical company focused on the development ...
April 3, 2019
Chiasma Announces Closing of $34.5 Million Offering of Common Stock and Full Exercise of Underwriters’ Option
WALTHAM, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
Page 2 of 138